首页|期刊导航|中西医结合肝病杂志|腹部取穴埋线法改善不同证型非酒精性脂肪性肝病患者腹部脂肪的疗效观察

腹部取穴埋线法改善不同证型非酒精性脂肪性肝病患者腹部脂肪的疗效观察OA

Observation on the efficacy of abdominal acupoint catgut embedding in reducing abdominal fat in patients with different TCM syndromes of non-alcoholic fatty liver disease

中文摘要英文摘要

目的:观察腹部取穴埋线法对不同证型非酒精性脂肪性肝病(NAFLD)患者腹部脂肪的调节作用,为临床个体化治疗提供依据.方法:选取上海市徐汇区大华医院中医肝病门诊确诊为NAFLD患者150例,随机分为对照组30例和埋线组120例(肝郁脾虚型、湿浊内停型、湿热蕴结型和痰瘀互结型各30例).对照组给予常规健康指导,埋线组在健康指导的基础上加用腹部取穴埋线治疗12周.观察腹部脂肪指标[体质量、体质量指数(BMI)、腰围、腰臀比、体脂比)]、腹部皮下脂肪厚度、肝肾回声比值及肝功能(ALT、AST、GGT)、血脂(TG、TC、LDL)的变化,并评估安全性.结果:埋线组的体质量、BMI、腰围、腰臀比、体脂比、腹部皮下脂肪厚度、肝肾回声比值及ALT、GGT、TG水平均较治疗前显著改善(P<0.05),且与对照组相比差异有统计学意义(P<0.05).其中肝郁脾虚型和湿浊内停型疗效更为显著.所有患者均未发生严重不良反应.结论:腹部取穴埋线法可改善NAFLD患者腹部脂肪的堆积,尤其对肝郁脾虚型和湿浊内停型患者疗效显著,安全性良好.

Objective:To observe the regulatory effect of abdominal acupoint catgut embedding therapy on abdominal fat in patients with non-alcoholic fatty liver disease(NAFLD)of different TCM syndromes,and to provide a basis for clinical individualized treatment.Methods:A total of 150 NAFLD patients diagnosed in our hospital were selected and randomly divided into a control group(30 cases)and a catgut embedding group(120 cases).The catgut embedding group was further subdivided into four subgroups according to TCM syndromes,with 30 cases in each subgroup:Liver Depression and Spleen Deficiency type,Dampness-Turbidity Retention type,Dampness-Heat Accumulation type,and Phlegm-Stasis Interbinding type.The control group received routine health guidance,while the catgut embedding group was given abdominal acupoint catgut embedding therapy for 12 weeks on the basis of the same health guidance.Changes in abdominal fat indicators(body weight,BMI,waist circumference,waist-to-hip ratio,body fat ratio),abdominal subcutaneous fat thickness,liver-kidney echo ratio,liver function indexes(ALT,AST,GGT),and blood lipid indexes(TG,TC,LDL)were observed,and the safety of the therapy was evaluated.Results:After treatment,the body weight,BMI,waist circumference,waist-to-hip ratio,body fat ratio,abdominal subcutaneous fat thickness,liver-kidney echo ratio,as well as the levels of ALT,GGT,and TG in the catgut embedding group were significantly improved compared with those before treatment(P<0.05),and the differences were statistically significant when compared with the control group(P<0.05).Among the four syndrome subgroups in the catgut embedding group,the therapeutic effects in the Liver Depression and Spleen Deficiency type and Dampness-Turbidity Retention type were more significant.No serious adverse reactions occurred in all patients.Conclusion:Abdominal acupoint catgut embedding therapy can improve abdominal fat accumulation in NAFLD patients,with particularly significant curative effects in patients with Liver Depression and Spleen Deficiency type and Dampness-Turbidity Retention type.It also has good safety.

杨晨;梅琪;沙红芳;崔剑巍

上海市徐汇区大华医院中医肝科(上海,200031)上海市徐汇区大华医院超声影像科上海市徐汇区大华医院超声影像科上海市徐汇区大华医院中医肝科(上海,200031)

医药卫生

非酒精性脂肪性肝病腹部穴位埋线腹部脂肪辨证分型疗效观察

NAFLDabdominal acupoint catgutembedding therapyabdominal fatsyndrome differentiation typingtherapeutic effect observation

《中西医结合肝病杂志》 2026 (8)

962-966,5

上海市十四五中医特色专科建设项目(孵化项目)(No.ZYTSZK2-19)

10.3969/j.issn.1005-0264.2026.008.004

评论